GNRH1 and posterior cortical atrophy: We found an increased predicted 5-year CVD risk score in men with PCa receiving GnRH agonists (10% increase in the score: HR, 1.25; 95% CI, 1.16-1.36) (Table 2; eTable 2 in the Supplement).